Mesenchymal Stem Cells‐Involved Strategies for Rheumatoid Arthritis Therapy
Year: 2024
Type: review
Abstract: Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by chronic inflammation of the joints and bone destruction. Because of systemic administration and poor targeting, traditional anti-rheumatic drugs have unsatisfactory treatment efficacy and strong side effects, including myelosuppression, liver or kidney function damage, and malignant tumors. Consequently, mesenchymal stem cells (MSCs)-involved therapy is proposed for RA therapy as a benefit of their immunosuppressive and tissue-repairing effects. This review summarizes the progress of MSCs-involved RA therapy through suppressing inflammation and promoting tissue regeneration and predicts their potential clinical application.
Source: Advanced Science
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $6,120
Funders: Innovative Research Group Project of the National Natural Science Foundation of China, National Natural Science Foundation of China, Chinese Academy of Sciences, Natural Science Foundation of Hebei Province, People's Government of Jilin Province, Youth Innovation Promotion Association of the Chinese Academy of Sciences, Department of Finance of Jilin Province, Key Technologies Research and Development Program, National Key Research and Development Program of China, Youth Innovation Promotion Association, Jilin Scientific and Technological Development Program
OpenAlex ID: W4392741846
